Royal Bank of Canada
HIMS icon

Royal Bank of Canada’s Hims & Hers Health HIMS Stock Holding History

Royal Bank of Canada’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.19M Buy
265,189
+92,227
+53% +$2.48M ﹤0.01% 2148
2026
Q1 		$3.59M Sell
172,962
-157,679
-48% -$3.72M ﹤0.01% 2660
2025
Q4 		$10.7M Sell
330,641
-408,639
-55% -$17.5M ﹤0.01% 1878
2025
Q3 		$41.9M Buy
739,280
+593,432
+407% +$30.4M 0.01% 1114
2025
Q2 		$7.27M Sell
145,848
-21,219
-13% -$959K ﹤0.01% 2273
2025
Q1 		$4.94M Sell
167,067
-58,294
-26% -$2.17M ﹤0.01% 2263
2024
Q4 		$5.45M Buy
225,361
+11,926
+6% +$295K ﹤0.01% 2250
2024
Q3 		$3.93M Buy
213,435
+96,042
+82% +$1.72M ﹤0.01% 2467
2024
Q2 		$2.37M Buy
117,393
+92,625
+374% +$1.54M ﹤0.01% 2782
2024
Q1 		$383K Sell
24,768
-35,770
-59% -$403K ﹤0.01% 4157
2023
Q4 		$537K Buy
60,538
+25,627
+73% +$189K ﹤0.01% 4197
2023
Q3 		$219K Buy
34,911
+9,130
+35% +$67.9K ﹤0.01% 4707
2023
Q2 		$243K Sell
25,781
-41,636
-62% -$413K ﹤0.01% 4562
2023
Q1 		$669K Buy
67,417
+37,372
+124% +$327K ﹤0.01% 3644
2022
Q4 		$192K Buy
30,045
+12,714
+73% +$72.4K ﹤0.01% 4917
2022
Q3 		$96K Sell
17,331
-5,708
-25% -$34.4K ﹤0.01% 5332
2022
Q2 		$104K Sell
23,039
-3,484
-13% -$14.9K ﹤0.01% 5309
2022
Q1 		$140K Buy
26,523
+4,126
+18% +$20.4K ﹤0.01% 5393
2021
Q4 		$147K Sell
22,397
-16,090
-42% -$116K ﹤0.01% 5650
2021
Q3 		$291K Buy
38,487
+11,337
+42% +$96K ﹤0.01% 4802
2021
Q2 		$296K Buy
27,150
+1,300
+5% +$15.5K ﹤0.01% 4731
2021
Q1 		$342K Buy
25,850
+25,830
+129,150% +$433K ﹤0.01% 4492
2020
Q4 		$0 Buy
+20
New +$222 ﹤0.01% 7154
2020
Q3 		– Sell
-49,800
Closed -$506K – 6745
2020
Q2 		$506K Hold
49,800
– – ﹤0.01% 3759
2020
Q1 		$498K Sell
49,800
-200
-0.4% -$1.99K ﹤0.01% 3613
2019
Q4 		$495K Buy
+50,000
New +$493K ﹤0.01% 4000

Other funds holding HIMS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Royal Bank of Canada's HIMS Position: Q2 2026 in Review

Royal Bank of Canada increased its Hims & Hers Health (HIMS) stake by 53% in Q2 2026, buying an estimated $2.48M and bringing the position to 265,189 shares worth $9.19M. The position accounts for ﹤0.01% of the portfolio, ranked #2148.

Royal Bank of Canada first reported a position in HIMS in Q4 2019 and has held it in 26 quarters since. The position peaked at $41.9M in Q3 2025. 504 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • Royal Bank of Canada held 265,189 shares of Hims & Hers Health worth $9.19M as of Q2 2026.
  • Royal Bank of Canada bought 92,227 Hims & Hers Health shares in Q2 2026, an estimated $2.48M.
  • Hims & Hers Health made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #2148 holding.
  • Royal Bank of Canada first reported a position in Hims & Hers Health in Q4 2019 and has held it in 26 quarters since.
  • Royal Bank of Canada's Hims & Hers Health position peaked at $41.9M in Q3 2025.
  • 504 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.